Mycronic (MYCR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Dec, 2025Executive summary
Net sales rose 40% year-over-year in Q3 to SEK 1,780 million, driven mainly by Pattern Generators, with support from High Volume and Global Technologies.
EBIT more than doubled to SEK 547 million, with EBIT margin improving to 31% from 21% in Q3 2023.
Order intake declined 1% to SEK 1,459 million; order backlog at SEK 4,379 million due to higher sales than order intake.
Acquisition of Modus High-Tech Electronics in Germany post-quarter enhances High Volume division's technical capabilities.
For the first nine months, net sales increased 34% to SEK 4,999 million, and EBIT reached SEK 1,494 million, surpassing the full-year 2023 result.
Financial highlights
Pattern Generators sales surged 86% year-over-year to SEK 807 million, with a gross margin of 73% and EBIT margin of 62%; order intake down 51%.
High Flex division saw net sales down 7% to SEK 353 million, EBIT margin at 9%, and order intake down 5%.
High Volume division reported net sales up 37% to SEK 336 million, EBIT margin at 14%, and order intake up 56%.
Global Technologies division achieved net sales up 31% to SEK 284 million, EBIT margin at 5%, and order intake up 64%.
Cash and cash equivalents at September end: SEK 2,532 million; net cash position: SEK 2,323 million.
Outlook and guidance
Full-year 2024 net sales target of SEK 6.5 billion reaffirmed.
No expectation of a quick turnaround in European High Flex markets; softness likely to persist for several quarters.
Positive long-term outlook for display industry driven by shift to larger AMOLED screens, though timing of investments remains uncertain.
Latest events from Mycronic
- Record annual sales, Q4 order drop, strong Global Technologies, and four acquisitions.MYCR
Q4 20255 Feb 2026 - Record sales and EBIT, revised 2025 outlook, and acquisitions amid tariff uncertainty.MYCR
Q1 202521 Dec 2025 - Record year with double-digit growth, strong margins, and increased shareholder returns.MYCR
Q4 202417 Dec 2025 - Q2 order intake and sales surged, driving upgraded 2024 guidance and new climate targets.MYCR
Q2 202415 Dec 2025 - Order intake up 67% but net sales and EBIT margin declined; 2025 outlook remains strong.MYCR
Q3 202523 Oct 2025 - Q2 net sales up 35%, order intake down, and 2025 sales guidance raised after key acquisitions.MYCR
Q2 202511 Jul 2025